Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators

被引:2
|
作者
O'Grady, Megan A. [1 ]
Elkington, Katherine S. [2 ,4 ]
Robson, Gail [5 ]
Achebe, Ikenna Y. [4 ]
Williams, Arthur Robin [3 ]
Cohall, Alwyn T. [6 ]
Cohall, Renee [6 ]
Christofferson, Monica [7 ]
Garcia, Alejandra [7 ]
Ramsey, Kelly S. [8 ]
Lincourt, Pat [8 ]
Tross, Susan [2 ,3 ]
机构
[1] Univ Connecticut, Sch Med, Dept Publ Hlth Sci, 263 Farmington Ave, Farmington, CT 06030 USA
[2] Columbia Univ, New York State Psychiat Inst, HIV Ctr Clin & Behav Studies, New York, NY USA
[3] New York State Psychiat Inst & Hosp, Div Subst Use Disorders, New York, NY USA
[4] Columbia Univ, New York Psychiat Inst, Ctr Behav Hlth & Youth Justice, New York, NY USA
[5] Callen Lorde Community Hlth Ctr, New York, NY USA
[6] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA
[7] Ctr Justice Innovat, New York, NY USA
[8] New York State Off Addict Serv & Supports, Albany, NY USA
基金
美国国家卫生研究院;
关键词
Opioid use disorder; Opioid intervention court; Medications for opioid use disorder; Criminal justice; Opioid overdose; Courts; Substance use disorder treatment; MEDICATION-ASSISTED TREATMENT; DRUG COURTS; OUTCOMES;
D O I
10.1186/s13011-024-00593-y
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
BackgroundPeople with opioid use disorder (OUD) are frequently in contact with the court system and have markedly higher rates of fatal opioid overdose. Opioid intervention courts (OIC) were developed to address increasing rates of opioid overdose among court defendants by engaging court staff in identification of treatment need and referral for opioid-related services and building collaborations between the court and OUD treatment systems. The study goal was to understand implementation barriers and facilitators in referring and engaging OIC clients in OUD treatment.MethodsSemi-structured interviews were conducted with OIC stakeholders (n = 46) in 10 New York counties in the United States, including court coordinators, court case managers, and substance use disorder treatment clinic counselors, administrators, and peers. Interviews were recorded and transcribed and thematic analysis was conducted, guided by the Exploration, Preparation, Implementation, Sustainment (EPIS) framework, employing both inductive and deductive coding.ResultsResults were conceptualized using EPIS inner (i.e., courts) and outer (i.e., OUD treatment providers) implementation contexts and bridging factors that impacted referral and engagement to OUD treatment from the OIC. Inner factors that facilitated OIC implementation included OIC philosophy (e.g., non-punitive, access-oriented), court organizational structure (e.g., strong court staff connectedness), and OIC court staff and client characteristics (e.g., positive medications for OUD [MOUD] attitudes). The latter two also served as barriers (e.g., lack of formalized procedures; stigma toward MOUD). Two outer context entities impacted OIC implementation as both barriers and facilitators: substance use disorder treatment programs (e.g., attitudes toward the OIC and MOUD; operational characteristics) and community environments (e.g., attitudes toward the opioid epidemic). The COVID-19 pandemic and bail reform were macro-outer context factors that negatively impacted OIC implementation. Facilitating bridging factors included staffing practices that bridged court and treatment systems (e.g., peers); barriers included communication and cultural differences between systems (e.g., differing expectations about OIC client success).ConclusionsThis study identified key barriers and facilitators that OICs may consider as this model expands in the United States. Referral to and engagement in OUD treatment within the OIC context requires ongoing efforts to bridge the treatment and court systems, and reduce stigma around MOUD.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Navigating barriers and embracing facilitators of connection: insights from peer recovery specialists working with individuals with substance use disorder and criminal justice involvement: a qualitative analysis
    Sutter-Barrett, Rebecca
    Spencer, Nancy R. B.
    Elnahas, Nora
    Hurd, Rebecca
    Delaney, Margaret
    Bivens, Aman
    HEALTH & JUSTICE, 2025, 13 (01)
  • [42] Barriers to women's disclosure of and treatment for substance use during pregnancy: A qualitative study
    Oni, Helen Tosin
    Drake, James Alfred
    Dietze, Paul
    Higgs, Peter
    Islam, M. Mofizul
    WOMEN AND BIRTH, 2022, 35 (06) : 576 - 581
  • [43] Understanding the barriers and facilitators of healthcare services for brain injury and concurrent mental health and substance use issues: a qualitative study
    Grewal, Jasleen
    Kennedy, Cole J.
    Mamman, Rinni
    Biagioni, Janelle Breese
    Garcia-Barrera, Mauricio A.
    Schmidt, Julia
    BMC HEALTH SERVICES RESEARCH, 2024, 24 (01)
  • [44] Engagement in substance use disorder treatment after an emergency department visit among persons at high risk of opioid overdose: A prediction analysis
    Bhondoekhan, Fiona
    Li, Yu
    Hallowell, Benjamin D.
    Mahoney, Linda
    Daly, Mackenzie M.
    Goulet, Jamieson
    Beaudoin, Francesca L.
    Chambers, Laura C.
    Marshall, Brandon D. L.
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2024, 13
  • [45] Staff perspectives of barriers and facilitators to implementation of the Consult for Addiction Treatment and Care in Hospitals (CATCH) program in New York City safety net hospitals
    Bunting, Amanda M.
    Fawole, Adetayo
    Fernando, Jasmine
    Appleton, Noa
    King, Carla
    Textor, Lauren
    Schatz, Daniel
    McNeely, Jennifer
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2025, 168
  • [46] Overcoming barriers to traditional care delivery and pharmacy challenges: a qualitative study of buprenorphine, telehealth, and a digital therapeutic for opioid use disorder
    Monico, Laura B.
    Eastlick, Megan
    Michero, Darcy
    Pielsticker, Peyton
    Glasner, Suzette
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2025, 20 (01)
  • [47] A qualitative study to determine perspectives of clinicians providing telehealth opioid use disorder treatment
    Burke, Barbara
    Miller, Emily
    Clear, Brian
    Weiner, Scott G.
    DRUG AND ALCOHOL DEPENDENCE, 2024, 256
  • [48] Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York
    Charles J. Neighbors
    Sugy Choi
    Shannon Healy
    Rajeev Yerneni
    Tong Sun
    Liudmila Shapoval
    Substance Abuse Treatment, Prevention, and Policy, 14
  • [49] Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York
    Neighbors, Charles J.
    Choi, Sugy
    Healy, Shannon
    Yerneni, Rajeev
    Sun, Tong
    Shapoval, Liudmila
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2019, 14 (1)
  • [50] Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study
    David, Allison R.
    Sian, Carlos R.
    Gebel, Christina M.
    Linas, Benjamin P.
    Samet, Jeffrey H.
    Martinez, Linda S. Sprague
    Muroff, Jordana
    Bernstein, Judith A.
    Assoumou, Sabrina A.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 142